Purchase Order 75A50121P00054
Award Date 9/20/21
Potential Completion Date 3/31/24
Potential Value $9.1M
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
South San Francisco, CA 94080, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This purchase order, valued at $6.96 million, was awarded by the Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response to Monogram Biosciences, Inc. to establish high-throughput SARS-CoV-2 neutralizing antibody immunoassay capability and test human serum samples. As a subsidiary of Laboratory Corporation of America Holdings, Monogram will perform this work establishing a testing capability and analyzing samples at its facility in South San...
- On November 29, 2021, the Office of the Assistant Secretary for Preparedness and Response (ASPR) awarded a $38.0 million firm fixed-price definitive contract to Monogram Biosciences, Inc. for the development and delivery of a high-throughput SARS-CoV-2 neutralizing antibody immunoassay capable of qualifying variants and testing human serum samples. The contract, which extends through September 30, 2029, is being performed at Monogram's laboratory facility in South San Francisco, California. As a...
- This firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, to Monogram Biosciences, Inc. for $17,665.00. The contract is for the PHENOSENSE HIV NEUT AB ASSAY, which provides testing and research services. Monogram Biosciences is a for-profit subsidiary of Laboratory Corporation of America Holdings that operates a laboratory in California. This award was not set aside for any...
- The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a $10.9 million firm fixed price purchase order to The Broad Institute, Inc. for serology and virus neutralization testing in support of coronavirus COVID-19 response efforts. Performance will take place at the prime contractor's Cambridge, Massachusetts location through September 2021. No subcontractors or set aside designations were indicated. This award utilizes the prime...
- This award is a $130,100.00 firm fixed-price purchase order issued by the Department of Health and Human Services Centers for Disease Control and Prevention to the prime contractor, Gen-Probe Incorporated, a medical diagnostics company. The contract does not have a set-aside designation. Gen-Probe Incorporated provides a variety of medical testing products and services to federal agencies, including the Defense Health Agency, Department of Veterans Affairs, and Department of the Navy. This...
- This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services (HHS) to Laboratory Corporation of America (LabCorp) on March 10, 2016 with a ceiling value of $45,000.00. The contract was not set aside for any specific business type. Under this contract, LabCorp is providing laboratory testing services related to Congenital Adrenal Hyperplasia and other medical testing. LabCorp has also received subcontract awards from Leidos Biomedical Research Inc....
- This is a $9,850,000.00 firm fixed price purchase order awarded by the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response (ASPR) to Luminex Corporation. The contract is to expand the use of Luminex's ARIES SARS-CoV-2 assay, which is a molecular diagnostic test for COVID-19. This award was not set aside for any specific business type. Luminex is a manufacturer of biological testing technologies, including multiplex diagnostic solutions,...
- This is a firm fixed-price purchase order awarded by the Defense Health Agency to Gen-Probe Incorporated, a medical diagnostics company that produces molecular diagnostic testing systems and assays. The contract is for the delivery of APTIMA SARS-CoV-2 tests to detect COVID-19, with a potential value of $745,185.00 and a completion date of March 31, 2023. The contract is part of the agency's efforts to procure necessary medical supplies related to the Coronavirus COVID-19 national interest...
- The U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response (ASPR), awarded Cepheid Inc. a definitive contract valued at $103.6 million on July 23, 2021, to establish a platform for diagnosis and surveillance of emerging pandemic threats. The contract, which extends through December 31, 2029, was awarded without a set-aside designation and operates under a cost-plus-no-fee pricing structure. The award originated from a Broad Agency...
- This is a $97,492,572.50 definitive, firm-fixed-price contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS) to Quidel Corp, a manufacturer of medical diagnostics and supplies, for the procurement of over-the-counter (OTC) COVID-19 tests. The contract has an ultimate completion date of April 7, 2028 and does not use a set-aside designation. Quidel Corp, which is based in San Diego, California,...